GSA Capital Partners’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

GSA Capital Partners’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-27,000	Closed	-$404K	–	2138
2016 Q2	$404K	Sell	27,000 -5,461	-17%	-$70.2K	0.02%	1200
2016 Q1	$395K	Buy	32,461 +4,501	+16%	+$63.1K	0.03%	1158
2015 Q4	$445K	Buy	+27,960	New	+$440K	0.02%	1235
2015 Q2	–	Sell	-43,904	Closed	-$1.02M	–	2354
2015 Q1	$1.02M	Buy	+43,904	New	+$1.16M	0.04%	845
2014 Q3	–	Sell	-12,018	Closed	-$311K	–	2082
2014 Q2	$311K	Buy	+12,018	New	+$267K	0.01%	1399
2014 Q1	–	Sell	-10,627	Closed	-$270K	–	1951
2013 Q4	$270K	Buy	+10,627	New	+$240K	0.02%	1278

GSA Capital Partners's SGNT Position: Q3 2016 in Review

GSA Capital Partners sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 27,000 shares — an estimated $404K sold.

GSA Capital Partners first reported a position in SGNT in Q4 2013 and held it in 6 quarters. The position peaked at $1.02M in Q1 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

GSA Capital Partners reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
GSA Capital Partners sold 27,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $404K.
GSA Capital Partners first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 6 quarters.
GSA Capital Partners's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.02M in Q1 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on GSA Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.